Estalis 50/140


Matrix transdermal patch
scheduling status
S4
registration number
37/21.8.2/0456
What Estalis 50/140 contains
Estalis matrix transdermal patches contain 0,620 mg estradiol hemihydrate and 2,70 mg norethisterone acetate, providing a nominal release rate of 50 mcg estradiol and 140 mcg norethisterone acetate over a period of 3,5 to 4 days.
other ingredients
Silicone and acrylic adhesives, povidone, oleic acid and dipropylene glycol. The backing layer consists of a polyester film laminate. The protective (release) liner, which is removed before applying the patch to the skin, is a fluoropolymer coated polyester film.
Therapeutic classification
A21.8.2 Progesterones with or without estrogens.
© 2026 SAHPRA. ALL RIGHTS RESERVED